We employed an isogenic murine RCC model to investigate the impact of PBRM1 loss on tumor-autonomous IFNγ signaling and on the TME, measured the effect of PBRM1 loss on response to ICB, and validated our findings in human ccRCC datasets. Here, IFNG is linked to nonpapillary renal cell carcinoma.